Dersalazine

DB06251InvestigationalSmall molecule

Investigated for use/treatment in inflammatory bowel disease.

Chemical structure of Dersalazine
Primary indication
Investigated for use/treatment in inflammatory bowel disease.Curator reviewed
Formula / weight
C35H32N6O4 · 600.679 g/mol (avg)
Code names
UR-12746

Resolves to

Compound
UNIIWS1IH75AJTCAS188913-58-8
Structure
InChIKeyAYEAMZDTWLXZIJ-RKOUKRECSA-NSMILESCC1=NC2=CN=CC=C2N1CC1CCN(CC1)C(=O)\C=C(\C1=CC=CC=C1)C1=CC=C(C=C1)\N=N\C1=CC(C(O)=O)=C(O)C=C1
Targets
P25105PTAFR

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
377Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Dersalazine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In